Seng Cheng - Senior Vice President & Chief Scientific Officer, Rare Disease Research Unit @ Pfizer

Overview

CB Rank (Investor)

Primary Job Title Senior Vice President & Chief Scientific Officer, Rare Disease Research Unit
Primary Organization
Pfizer

Seng Cheng is a Senior Vice President and Chief Scientific Officer, Rare Disease Research Unit at Pfizer. He Attended University of London.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Homology Medicines	Pfizer Breakthrough Growth Initiative	Yes	Post-IPO Equity - Homology Medicines	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

is the

Senior Vice President & Chief Scientific Officer, Rare Disease Research Unit

. Additionally,

has had

past job as the

Global Head of Research, Rare Diseases

Pfizer Senior Vice President & Chief Scientific Officer, Rare Disease Research UnitJul 2018

Organization Name	Title At Company	Start Date	End Date
Sanofi	Global Head of Research, Rare Diseases	—	Jul 2018

Hub Name	CB Rank (Hub)
Venture Capital Investors with Investments in Massachusetts	1,328
Corporate VC Investors with Investments in New England	17,915
Private Equity Stage Investors with Investments in Greater Boston Area	5,197
Venture Stage Investors Corporate VC Investors	18,719
Private Equity Stage Investors with Investments in New England	4,900
Corporate VC Investors with Investments in East Coast	12,161
Corporate VC Investors with Investments in Greater Boston Area	20,055
Private Equity Stage Investors Corporate VC Investors	26,877
East Coast Biotechnology Public Companies	44,680
Northeastern US Corporate VC Investors	38,916

Number of Events

has participated in

event,

Apr 24, 2017

There is no recent news or activity for this profile.